Company Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Neuronetics, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
3.8 ^USD	-0.78%		-12.04%	+31.03%

Apr. 10	Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	CI
Mar. 28	Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	CI

Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Number of employees: 203

USD in Million	2022	Weight	2023	Weight	Delta
Treatment Sessions 72.4 %	45	69.7 %	52	72.4 %	+13.69%
NeuroStar Advanced Therapy System 24.0 %	17	26.7 %	17	24.0 %	-1.71%
Other 3.7 %	2	3.7 %	3	3.7 %	+9.21%

USD in Million	2022	Weight	2023	Weight	Delta
United States 97.2 %	63	97.2 %	69	97.2 %	+9.35%
International 2.8 %	2	2.8 %	2	2.8 %	+11.78%

Managers	Title	Age	Since
Keith Sullivan CEO	Chief Executive Officer	66	20-07-13
Stephen Furlong DFI	Director of Finance/CFO	60	-
Cory Anderson CTO	Chief Tech/Sci/R&D Officer	-	21-02-28
W. Macan CMP	Compliance Officer	51	20-01-20
Lisa Metzner-Rosas SAM	Sales & Marketing	-	23-04-30
Rick Grubbs AUD	Comptroller/Controller/Auditor	-	-
Sara Grubbs PRN	Corporate Officer/Principal	-	20-10-04
Todd Cushman PRN	Corporate Officer/Principal	-	21-05-31

Members of the board	Title	Age	Since
Robert Cascella CHM	Chairman	69	21-03-31
Sheryl Conley BRD	Director/Board Member	63	19-09-30
Wilfred Jaeger BRD	Director/Board Member	67	05-04-30
John Bakewell BRD	Director/Board Member	62	20-03-31
Glenn Muir BRD	Director/Board Member	65	17-06-30
Keith Sullivan CEO	Chief Executive Officer	66	20-07-13
Joe Capper BRD	Director/Board Member	60	22-12-31
Megan Rosengarten BRD	Director/Board Member	47	21-08-01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	29,974,617	27,989,953 ( 93.38 %)	0	93.38 %

Name	Equities	%	Valuation
Cannell Capital LLC 9.307 %	2,769,268	9.307 %	13 M $
Archon Capital Management LLC 8.526 %	2,537,097	8.526 %	12 M $
Divisadero Street Capital Management LP 5.173 %	1,539,382	5.173 %	7 M $
Balyasny Asset Management LP 4.764 %	1,417,722	4.764 %	7 M $
Keith Sullivan 4.612 %	1,372,278	4.612 %	7 M $
Vanguard Global Advisers LLC 4.547 %	1,353,144	4.547 %	6 M $
SILVERCREST ASSET MANAGEMENT GROUP INC. 3.786 %	1,126,484	3.786 %	5 M $
Kent Lake Capital LLC 3.751 %	1,116,041	3.751 %	5 M $
First Eagle Investment Management LLC 2.608 %	776,009	2.608 %	4 M $
Parian Global Management LP 2.555 %	760,410	2.555 %	4 M $

Neuronetics, Inc.

3222 Phoenixville Pike

19355, Malvern

+610 640 4202

http://www.neuronetics.com

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.8 USD

Average target price

7 USD

Spread / Average Target

+84.21%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NEURONETICS, INC.	+31.03%	115M
THERMO FISHER SCIENTIFIC	+2.64%	207B
DANAHER CORPORATION	+1.80%	175B
INTUITIVE SURGICAL, INC.	+8.59%	132B
BOSTON SCIENTIFIC CORPORATION	+16.47%	99.1B
SIEMENS HEALTHINEERS AG	-3.42%	60.89B
EDWARDS LIFESCIENCES CORPORATION	+12.71%	52.04B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.61%	45.48B
AGILENT TECHNOLOGIES, INC.	-4.53%	38.81B
GE HEALTHCARE TECHNOLOGIES INC.	+9.27%	38.77B

Other Advanced Medical Equipment & Technology